Enovis Company Description

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide.

It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy.

The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals.

The company’s Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools.

The company distributes its products through independent distributors and directly under the ESAB and DJO brands.

Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Enovis Corporation

Country	United States
Founded	1995
Industry	Industrial - Capital Goods
Sector	Industrials
Employees	6,550
CEO	Matthew Trerotola

Contact Details

Address: 2711 Centerville Road Wilmington, Delaware 19808 United States
Phone	302 252 9160
Website	enovis.com

Stock Details

Ticker Symbol	0I1B
Exchange	London Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US1940145022
SIC Code	3842

Key Executives

Name	Position
Matthew Trerotola	Chief Executive Officer
Phillip Berry	Chief Financial Officer
Derek Leckow	Head of Investor Relations